Skip Navigation

Profile

David X. Zhao, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

72 Ratings
8 Comments
 

David X. Zhao, M.D.

Section Chief,
Professor,


Surgical Sciences-Cardiothoracic Surgery

Clinical Interests

Cardiac Critical Care, Interventional Cardiac Catheterization, Valvular Heart Disease, Adult Congenital Heart Disease, Cardiac Disease, Percutaneous Cardiac Interventions, Structural Heart Disease, Cardiac Catheterization, Cardiology (clinical), Cardiology (interventional)

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6674
Department: 336-716-4342

Insurance Accepted »

Additional Languages

Chinese-Shanghai

Education & Training

  • M.D., Shanghai Medical University-China, 1985
  • Ph.D., University Of Queensland-Australia, 1992
  • Residency, Surgery, Zhongshan Hospital, 1989
  • Fellowship, Cardiothoracic Surgery, Prince Charles Hospital, 1992
  • Fellowship, Transplant Surgery, Vanderbilt Univ Medical School, 1994
  • Residency, Internal Medicine, Vanderbilt Univ Medical Center, 1997
  • Fellowship, Internal Medicine, Harvard Medical School, 2000
  • Fellowship, Internal Medicine, Harvard Medical School, 2001

Board Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Interventional Cardiology

Memberships

  • Int'l Soc of Heart Transplanta
  • Soc Of Cardiovascular & Interv
  • American College of Cardiology
  • Am Heart Association

NPI Number

  • 1366411159
David X. Zhao, M.D.

Doctor Rating

4.6 out of 5

72 Ratings
8 Comments
 

David X. Zhao, M.D.

Section Chief, Cardiology
Professor, Cardiology
Heart Center Administration
Surgery Vascular
Surgical Sciences-Cardiothoracic Surgery

Research Interests

Myocardial Infarction; Coronary Artery Bypass; Aortic Valve Stenosis; Heart Valve Prosthesis Implantation; Coronary Artery Disease
More »

Contact Information

Request An Appointment

Academic: 336-716-4342 | Department: 336-716-4342

Recent Publications

TIME trial: effect of timing of stem cell delivery following ST-elevation myocardial infarction on the recovery of global and regional left ventricular function: final 2-year analysis. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh AR, Yang PC, Zhao D, Ellis SG, Forder JR, Perin EC, Penn MS, Hatzopoulos AK, Chambers JW, Baran K, Raveendran G, Gee AP, Taylor DA, Moye L, Ebert RF, Simari RD.. Circ Res. 2018;122(3):479-488.

New concepts in an old disease: exercise intolerance in moderate mitral stenosis [editorial comment]. Kitzman DW, Upadhya B, Zhao D.. JACC Cardiovasc Imaging. 2017;10(6):634-636.

Polymer-free drug-coated coronary stents in patients with stable coronary artery disease at high bleeding risk. Panchal HB, Daggubati R, Zhao D, Rao SV, Paul T.. Curr Cardiol Rep. 2017;19(2):12.

Endovascular management of major vascular access site complications during transcatheter aortic valve implantation (TAVI) [abstract]. Majeed MU, Green KD, Fudim M, Robbins MA, Zhao DX.. Circ Cardiovasc Qual Outcomes. 2017;10(Suppl 3):A016.

Cardiovascular disease and renal transplantation. Applegate RJ, Belford PM, Gandhi SK, Kutcher MA, Santos RM, Zhao DX. In: Orlando G, Remuzzi G, Williams DF, eds. Kidney transplantation, bioengineering and regeneration. London: Academic Press;2017: 543-554.

Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach. Drafts BC, Choi CH, Sangal K, Cammarata MW, Applegate RJ, Gandhi SK, Kincaid EH, Kon N, Zhao DX.. Catheter Cardiovasc Interv. 2017;():.

Bioprosthetic tricuspid valve thrombosis: percutaneous PFO closure to improve hypoxia and respiratory failure. Flueckiger P, Singleton M, Vasu S, Zhao D.. Catheter Cardiovasc Interv. 2017;():.

Outcomes of saphenous vein graft intervention with and without embolic protection device: a comprehensive review and meta-analysis. Paul TK, Bhatheja S, Panchal HB, Zheng S, Banerjee S, Rao SV, Guzman L, Beohar N, Zhao D, Mehran R, Mukherjee D.. Circ Cardiovasc Interv. 2017;10(12):e005538.

Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR): a comparison of failed stentless and stented surgical bio-prosthetic aortic valve [abstract]. Choi C, Cheng V, Qureshi W, Green D, Kon N, Kincaid T, Gandhi S, Applegate R, Zhao D.. J Am Coll Cardiol. 2017;70(18 Suppl):B265.

Identification of bone marrow cell subpopulations associated with improved functional outcomes in patients with chronic left ventricular dysfunction: an embedded cohort evaluation of the FOCUS-CCTRN trial. Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Moye L, Ebert RF,.. Cell Transplant. 2016;25(9):1675-1687.

2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG,.. Circulation. 2016;133(11):1135-1147.

2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE Jr,.. Catheter Cardiovasc Interv. 2016;87(6):1001-1019.

Is atrial fibrillation important for low gradient severe aortic stenosis with preserved ejection fraction?[abstract]. Shen H, Stacey B, Zhao D, Upadhya B, Vasu S, Pu M.. J Am Coll Cardiol. 2016;67(13 Suppl):2231.

Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study. Puskas JD, Halkos ME, DeRose JJ, Bagiella E, Miller MA, Overbey J, Bonatti J, Srinivas VS, Vesely M, Sutter F, Lynch J, Kirkwood K, Shapiro TA, Boudoulas KD, Crestanello J, Gehrig T, Smith P, Ragosta M, Hoff SJ, Zhao D, Gelijns AC, Szeto WY, Weisz G,.. J Am Coll Cardiol. 2016;68(4):356-365.

Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Moye L, Cogle CR, Taylor DA.. Am Heart J. 2016;179():142-150.

The NHLBI TIME Trial: role of microvascular obstruction in 2-year clinical and MRI follow-up [abstract]. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Taylor DA, Chugh AR, Yang PC, Ellis SG, Zhao DX, Penn MS, Forder JR, Ebert RF, Moye LA, Simari RJ.. Circulation. 2016;134(25):E710.

A novel scoring system may identify high risk patients with low gradient severe aortic stenosis with preserved ejection fraction [abstract]. Shen H, Applegate B, Zhao D, Stacey B, Upadhya B, Gandhi S, Pu M.. Eur Heart J. 2016;37(Suppl 1):746.

Clinical outcomes in different types of aortic stenosis as assessed by Doppler echocardiography. Brandon Stacey R [sic] [Stacey RB], Meng M, Byrum Iii GV, Gilbert ON, Upadhya B, Rodriguez C, Zhao D, Pu M.. J Heart Valve Dis. 2016;25(6):672-678.

Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the 'classic' responders. Halliday SJ, Hemnes AR, Robbins IM, Pugh ME, Zhao DX, Piana RN, Fong PP, Brittain EL.. J Heart Lung Transplant. 2015;34(3):312-318.

Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, Wu JC, Sayre SL, Orozco A, Zierold C, Simari RD, Moye L, Cogle CR, Taylor DA.. Circ Res. 2015;116(1):99-107.

Ask the experts: should the CMS NCD requirement for surgical and interventional co-operators for TAVR procedures be dropped?. Alexander JC, Chawla A, Zhao DX, Beohar N, Abdel-Wahab M.. Cardiac Intervent Today. 2015;9():68-70.

Transcatheter aortic valve replacement customization based on paravalvular aortic regurgitation location [abstract]. Gilbert ON, Hermann DD, Alvarez L, Deutsch C, Aldrich A, Sacrinty M, Pu M, Stacey R, Applegate R, Gandhi S, Zhao D.. J Am Coll Cardiol. 2015;65(10 Suppl):A1791.

Importance of stroke volume index assessed by echocardiography for stratification of low gradient severe aortic stenosis with normal left ventricular function [abstract]. Shen H, Stacey B, Applegate B, Zhao D, Vasu S, Upadhya B, Gandhi S, Pu M.. Circulation. 2015;132(Suppl 3):A10881.

Utility of stroke volume index for stratification of patients with low gradient severe aortic stenosis and normal left ventricular ejection fraction [abstract]. Shen H, Stacey B, Applegate B, Zhao D, Vasu S, Upadhya B, Gandhi S, Liu R, Wei M, Pu M.. Circulation. 2015;132(Suppl 3):A19826.

High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH.. Circ Heart Fail. 2014;17(1):116-122.

Standardizing definitions for hybrid coronary revascularization [editorial]. Harskamp RE, Bonatti JO, Zhao DX, Puskas JD, de Winter RJ, Alexander JH, Halkos ME.. J Thorac Cardiovasc Surg. 2014;147(2):556-560.

Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Cogle CR, Wise E, Meacham AM, Zierold C, Traverse JH, Henry TD, Perin EC, Willerson JT, Ellis SG, Carlson M, Zhao DX, Bolli R, Cooke JP, Anwaruddin S, Bhatnagar A, da Graca Cabreira-Hansen M, Grant MB, Lai D, Moye L, Ebert RF, Olson RE, Sayre SL,.. Circ Res. 2014;115(10):867-874.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Cardiology

Clinical Interests

Cardiac Critical Care, Interventional Cardiac Catheterization, Valvular Heart Disease, Adult Congenital Heart Disease, Cardiac Disease, Percutaneous Cardiac Interventions, Structural Heart Disease, Cardiac Catheterization, Cardiology (clinical), Cardiology (interventional)
David X. Zhao, M.D.

David X. Zhao, M.D.

Section Chief, Cardiology
Professor, Cardiology
Heart Center Administration
Surgery Vascular
Surgical Sciences-Cardiothoracic Surgery

Request An Appointment

Doctor Rating

4.6 out of 5

David X. Zhao, M.D.72 Ratings
8 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.6
Patients' confidence in CP
4.7
Time CP spent with patient
4.5
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

2/28/2018

I was seeking second opinion on my condition. *Dr. Zhao was much more helpful then my original doctor. He seemed very concerned about my condition, offered option NOT identified by original doctor.

2/7/2018

I'm very grateful to have *Dr. Zhao as my doctor.

12/28/2017

It was very good.

8/29/2017

Love him!!!! Smart, caring..

8/1/2017

Best I have EVER had!

8/1/2017

*Dr. Zhao told me on 3-9-17 my heart was dying & got me into a clinical trial at Cedars Sinai Hosp. in LA to save my life. He truly cares about me & tryping to save my life. Wouldn't want any other doctor on my case.

6/15/2017

*Dr. Zhao obviously worked at giving us the time we needed, but also was obviously on a TIGHT schedule.

6/1/2017

The was very polite, showed concern in my health, explained everything I need to know. He is a great doctor, I'm lucky to have him.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.